Office of the Director, Office of Biotechnology Activities; Notice of a Safety Symposium, 25282-25283 [2010-10864]
Download as PDF
25282
jlentini on DSKJ8SOYB1PROD with NOTICES
ACTION:
Federal Register / Vol. 75, No. 88 / Friday, May 7, 2010 / Notices
Notice of public workshop.
SUMMARY: The Food and Drug
Administration (FDA), Office of
Regulatory Affairs (ORA), Southwest
Regional Office (SWRO), in cosponsorship with the University of
Arkansas (UA) Institute of Food Science
and Engineering, is announcing a public
workshop entitled ‘‘Food Protection
Workshop.’’ This public workshop is
intended to provide information about
food safety, food defense, the
regulations authorized by the Public
Health Security and Bioterrorism
Preparedness and Response Act of 2002
(the Bioterrorism Act), and other related
subjects to the Food Protection Plan as
it relates to food establishments such as
farms, manufacturers, processors,
distributors, retailers, and restaurants.
Date and Time: This public workshop
will be held on June 9 and 10, 2010,
from 8 a.m. to 5 p.m.
Location: The public workshop will
be held at the Continuing Education
Center, Two East Center St.,
Fayetteville, AR (located downtown).
Contact: David Arvelo, Food and Drug
Administration, Southwest Regional
Office, 4040 North Central Expressway,
suite 900, Dallas, TX 75204, 214–253–
4952, FAX: 214–253–4970, or e-mail:
david.arvelo@fda.hhs.gov.
For information on accommodation
options, visit https://www.uark.edu/ua/
foodpro/Workshops/Food_Safety_
Defense_Workshop.html or contact
Steven C. Seideman, 2650 North Young
Ave., Institute of Food Science &
Engineering, University of Arkansas,
Fayetteville, AR 72704, 479–575–4221,
FAX: 479–575–2165, or e-mail:
seideman@uark.edu.
Registration: You are encouraged to
register by May 26, 2010. The University
of Arkansas has a $250 registration fee
to cover the cost of facilities, materials,
speakers, and breaks. There is no fee for
FDA employees. Seats are limited;
please submit your registration as soon
as possible. Course space will be filled
in order of receipt of registration. Those
accepted into the course will receive
confirmation. Registration will close
after the course is filled. Registration at
the site is not guaranteed but may be
possible on a space available basis on
the day of the public workshop
beginning at 8 a.m. The cost of
registration at the site is $350 payable
to: ‘‘The University of Arkansas.’’ If you
need special accommodations due to a
disability, please contact Steven C.
Seideman (see Contact) at least 14 days
in advance.
To register, please visit https://
www.uark.edu/ua/foodpro/Workshops/
Food_Safety_Defense_Workshop.html to
VerDate Mar<15>2010
19:19 May 06, 2010
Jkt 220001
register online or submit a check or
money order for $250 payable to the
‘‘The University of Arkansas.’’ Mail to:
Institute of Food Science & Engineering,
University of Arkansas, 2650 North
Young Ave., Fayetteville, AR 72704
along with the following information:
Your name, affiliation, mailing address,
phone number, fax, e-mail, and whether
special accommodations are required.
Transcripts: Transcripts of the public
workshop will not be available due to
the format of this workshop. Workshop
handouts may be requested at cost
through the Freedom of Information
Office (HFI–35), Food and Drug
Administration, 5600 Fishers Lane, rm.
12A–16, Rockville, MD 20857,
approximately 15 working days after the
public workshop at a cost of 10 cents
per page.
SUPPLEMENTARY INFORMATION: This
public workshop is being held in
response to the large volume of food
protection concerns from food
establishments (such as farms,
manufacturers, processors, distributors,
retailers, and restaurants) originating
from the area covered by the FDA Dallas
District Office. The SWRO presents this
workshop to help achieve objectives set
forth in section 406 of the Food and
Drug Administration Modernization Act
of 1997 (21 U.S.C. 393), which include
working closely with stakeholders and
maximizing the availability and clarity
of information to stakeholders and the
public. This is consistent with the
purposes of the Small Business
Representative Program, which are in
part to respond to industry inquiries,
develop educational materials, sponsor
workshops and conferences to provide
firms, particularly small businesses,
with firsthand working knowledge of
FDA’s guidance, requirements, and
compliance policies. This workshop is
also consistent with the Small Business
Regulatory Enforcement Fairness Act of
1996 (Public Law 104–121), as outreach
activities by Government agencies to
small businesses.
The goal of this public workshop is to
present information that will enable
food establishments (such as farms,
manufacturers, processors, distributors,
retailers, and restaurants) to better
comply with any regulations authorized
by the Public Health Security and
Bioterrorism Preparedness and
Response Act of 2002 (the Bioterrorism
Act) relevant to such establishments,
and to be aware of recommendations in
food protection guidance, especially in
light of growing concerns about food
safety and defense. Information
presented will be based on regulations,
guidances, and information previously
PO 00000
Frm 00098
Fmt 4703
Sfmt 4703
made available to the public. Topics to
be discussed at the workshop include:
(1) Food defense programs, (2) good
manufacturing practices, (3) reportable
food registry, (4) Hazard Analysis
Critical Control Point (HACCP), (5) good
agricultural practices, (6) food recalls,
(7) pathogens of public health concern,
and (8) risk management and
vulnerability assessments and other
related topics. For more information,
please visit https://www.uark.edu/ua/
foodpro/Workshops/Food_Safety_
Defense_Workshop.html. FDA expects
that participation in this public
workshop will provide regulated
industry with greater understanding of
the regulatory and guidance
perspectives on food protection and
increase voluntary compliance and food
defense awareness.
Dated: May 3, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010–10792 Filed 5–6–10; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, Office of
Biotechnology Activities; Notice of a
Safety Symposium
There will be a safety symposium
entitled ‘‘Gene-Modified T Cells:
Challenges in Clinical Trial Design with
Novel Receptors.’’ The meeting will be
open to the public, with attendance
limited to space available. Individuals
who plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
Contact Person listed below in advance
of the meeting. For further information
concerning this meeting contact Ms.
Chezelle George, Administrative
Assistant, Office of Biotechnology
Activities, Office of the Director,
National Institutes of Health, 6705
Rockledge Drive, Room 750, Bethesda,
MD 20892–7985, 301–496–9838,
georgec@mail.nih.gov.
Name of Committee: Recombinant DNA
Advisory Committee.
Date: June 15, 2010.
Time: 8 a.m. to 5:30 p.m.
Agenda: The Office of Biotechnology
Activities (OBA) and NIH Recombinant DNA
Advisory Committee will host a symposium
entitled ‘‘Gene Modified T Cells: Challenges
in Clinical Trial Design with Novel
Receptors’’ on June 15, 2010 at the Rockville
Hotel and Executive Center. Experts will
discuss data from trials conducted to date,
the selection of novel antigen targets, the
E:\FR\FM\07MYN1.SGM
07MYN1
Federal Register / Vol. 75, No. 88 / Friday, May 7, 2010 / Notices
potential risks of off-target effects and
clinical trial design strategies that can
maximize both anti-tumor effect and safety.
An agenda will be posted to OBA’s Web site
closer to the meeting date. Please check the
meeting agenda at https://oba.od.nih.gov/
rdna/rdna.html for more information.
Place: Rockville Hotel and Executive
Center, 1750 Rockville Pike, Rockville, MD
20892.
Contact Person: Chezelle George,
Administrative Assistant, Office of Science
Policy, Office of Biotechnology Activities,
National Institutes of Health, 6705 Rockledge
Drive, Suite 750–A1, Bethesda, MD 20892,
301–496–9838, georgec@mail.nih.gov.
Any interested person may file written
comments with the panel by forwarding the
statement to the Contact Person listed on this
notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Background information may be obtained by
contacting NIH OBA by e-mail
oba@od.nih.gov
Dated: April 29, 2010.
Jacqueline Corrigan-Curay,
Acting Director, Office of Biotechnology
Activities, National Institutes of Health.
[FR Doc. 2010–10864 Filed 5–6–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Internal Agency Docket No. FEMA–1906–
DR; Docket ID FEMA–2010–0002]
Mississippi; Major Disaster and
Related Determinations
jlentini on DSKJ8SOYB1PROD with NOTICES
AGENCY: Federal Emergency
Management Agency, DHS.
ACTION: Notice.
SUMMARY: This is a notice of the
Presidential declaration of a major
disaster for the State of Mississippi
(FEMA–1906–DR), dated April 29, 2010,
and related determinations.
DATES: Effective Date: April 29, 2010.
FOR FURTHER INFORMATION CONTACT:
Peggy Miller, Recovery Directorate,
Federal Emergency Management
Agency, 500 C Street, SW., Washington,
DC 20472, (202) 646–3886.
SUPPLEMENTARY INFORMATION: Notice is
hereby given that, in a letter dated April
29, 2010, the President issued a major
disaster declaration under the authority
of the Robert T. Stafford Disaster Relief
and Emergency Assistance Act, 42
U.S.C. 5121 et seq. (the ‘‘Stafford Act’’),
as follows:
I have determined that the damage in
certain areas of the State of Mississippi
VerDate Mar<15>2010
19:19 May 06, 2010
Jkt 220001
resulting from severe storms, tornadoes, and
flooding during the period of April 23–24,
2010, is of sufficient severity and magnitude
to warrant a major disaster declaration under
the Robert T. Stafford Disaster Relief and
Emergency Assistance Act, 42 U.S.C. 5121 et
seq. (the ‘‘Stafford Act’’). Therefore, I declare
that such a major disaster exists in the State
of Mississippi.
In order to provide Federal assistance, you
are hereby authorized to allocate from funds
available for these purposes such amounts as
you find necessary for Federal disaster
assistance and administrative expenses.
You are authorized to provide assistance
for debris removal (Category A) for 72 hours
of the State’s choosing and emergency
protective measures (Category B), limited to
direct Federal assistance, under the Public
Assistance program and Individual
Assistance in the designated areas, and
Hazard Mitigation throughout the State.
Consistent with the requirement that Federal
assistance is supplemental, any Federal
funds provided under the Stafford Act for
Public Assistance, Hazard Mitigation, and
Other Needs Assistance will be limited to 75
percent of the total eligible costs.
Further, you are authorized to make
changes to this declaration for the approved
assistance to the extent allowable under the
Stafford Act.
25283
Disaster Housing Operations for Individuals
and Households; 97.050, Presidentially
Declared Disaster Assistance to Individuals
and Households—Other Needs; 97.036,
Disaster Grants—Public Assistance
(Presidentially Declared Disasters); 97.039,
Hazard Mitigation Grant.
W. Craig Fugate,
Administrator, Federal Emergency
Management Agency.
[FR Doc. 2010–10789 Filed 5–6–10; 8:45 am]
BILLING CODE 9111–23–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Internal Agency Docket No. FEMA–1906–
DR; Docket ID FEMA–2010–0002]
Mississippi; Amendment No. 2 to
Notice of a Major Disaster Declaration
AGENCY: Federal Emergency
Management Agency, DHS.
ACTION: Notice.
The time period prescribed for the
implementation of section 310(a),
Priority to Certain Applications for
Public Facility and Public Housing
Assistance, 42 U.S.C. 5153, shall be for
a period not to exceed six months after
the date of this declaration.
The Federal Emergency Management
Agency (FEMA) hereby gives notice that
pursuant to the authority vested in the
Administrator, under Executive Order
12148, as amended, Michael Bolch, of
FEMA is appointed to act as the Federal
Coordinating Officer for this major
disaster.
The following areas of the State of
Mississippi have been designated as
adversely affected by this major disaster:
Choctaw and Yazoo Counties for
Individual Assistance.
Choctaw and Yazoo Counties for debris
removal (Category A), for 72 hours of the
State’s choosing and emergency protective
measures (Category B), limited to direct
Federal assistance, under the Public
Assistance program.
All counties in the State of Mississippi are
eligible to apply for assistance under the
Hazard Mitigation Grant Program.
The following Catalog of Federal Domestic
Assistance Numbers (CFDA) are to be used
for reporting and drawing funds: 97.030,
Community Disaster Loans; 97.031, Cora
Brown Fund; 97.032, Crisis Counseling;
97.033, Disaster Legal Services; 97.034,
Disaster Unemployment Assistance (DUA);
97.046, Fire Management Assistance Grant;
97.048, Disaster Housing Assistance to
Individuals and Households In Presidentially
Declared Disaster Areas; 97.049,
Presidentially Declared Disaster Assistance—
SUMMARY: This notice amends the notice
of a major disaster declaration for the
State of Mississippi (FEMA–1906–DR),
dated April 29, 2010, and related
determinations.
DATES: Effective Date: May 1, 2010.
FOR FURTHER INFORMATION CONTACT:
Peggy Miller, Recovery Directorate,
Federal Emergency Management
Agency, 500 C Street, SW., Washington,
DC 20472, (202) 646–3886.
SUPPLEMENTARY INFORMATION: The notice
of a major disaster declaration for the
State of Mississippi is hereby amended
to include the following areas among
those areas determined to have been
adversely affected by the event declared
a major disaster by the President in his
declaration of April 29, 2010.
Monroe and Union Counties for Individual
Assistance
Choctaw and Yazoo Counties for Public
Assistance, including direct Federal
assistance (already designated for Individual
Assistance and debris removal [Category A],
for 72 hours of the State’s choosing and
emergency protective measures [Category B],
limited to direct Federal assistance, under
the Public Assistance program).
Attala and Holmes Counties for Public
Assistance, including direct Federal
assistance, (already designated for Individual
Assistance).
The following Catalog of Federal Domestic
Assistance Numbers (CFDA) are to be used
for reporting and drawing funds: 97.030,
Community Disaster Loans; 97.031, Cora
Brown Fund; 97.032, Crisis Counseling;
97.033, Disaster Legal Services; 97.034,
Disaster Unemployment Assistance (DUA);
97.046, Fire Management Assistance Grant;
PO 00000
Frm 00099
Fmt 4703
Sfmt 4703
E:\FR\FM\07MYN1.SGM
07MYN1
Agencies
[Federal Register Volume 75, Number 88 (Friday, May 7, 2010)]
[Notices]
[Pages 25282-25283]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-10864]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, Office of Biotechnology Activities;
Notice of a Safety Symposium
There will be a safety symposium entitled ``Gene-Modified T Cells:
Challenges in Clinical Trial Design with Novel Receptors.'' The meeting
will be open to the public, with attendance limited to space available.
Individuals who plan to attend and need special assistance, such as
sign language interpretation or other reasonable accommodations, should
notify the Contact Person listed below in advance of the meeting. For
further information concerning this meeting contact Ms. Chezelle
George, Administrative Assistant, Office of Biotechnology Activities,
Office of the Director, National Institutes of Health, 6705 Rockledge
Drive, Room 750, Bethesda, MD 20892-7985, 301-496-9838,
georgec@mail.nih.gov.
Name of Committee: Recombinant DNA Advisory Committee.
Date: June 15, 2010.
Time: 8 a.m. to 5:30 p.m.
Agenda: The Office of Biotechnology Activities (OBA) and NIH
Recombinant DNA Advisory Committee will host a symposium entitled
``Gene Modified T Cells: Challenges in Clinical Trial Design with
Novel Receptors'' on June 15, 2010 at the Rockville Hotel and
Executive Center. Experts will discuss data from trials conducted to
date, the selection of novel antigen targets, the
[[Page 25283]]
potential risks of off-target effects and clinical trial design
strategies that can maximize both anti-tumor effect and safety. An
agenda will be posted to OBA's Web site closer to the meeting date.
Please check the meeting agenda at https://oba.od.nih.gov/rdna/rdna.html for more information.
Place: Rockville Hotel and Executive Center, 1750 Rockville
Pike, Rockville, MD 20892.
Contact Person: Chezelle George, Administrative Assistant,
Office of Science Policy, Office of Biotechnology Activities,
National Institutes of Health, 6705 Rockledge Drive, Suite 750-A1,
Bethesda, MD 20892, 301-496-9838, georgec@mail.nih.gov.
Any interested person may file written comments with the panel
by forwarding the statement to the Contact Person listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation
of the interested person. Background information may be obtained by
contacting NIH OBA by e-mail oba@od.nih.gov
Dated: April 29, 2010.
Jacqueline Corrigan-Curay,
Acting Director, Office of Biotechnology Activities, National
Institutes of Health.
[FR Doc. 2010-10864 Filed 5-6-10; 8:45 am]
BILLING CODE 4140-01-P